ArticleNucleic acid therapeutics2022

miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3.

Rui Jorge Nobre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.